Anna completed her MSci in Chemistry at Imperial College London. During that time, she embarked on a one-year placement at AstraZeneca Early Oncology DMPK department. There she was studying drug metabolism using various biological assays and state-of-the-art mass spectrometer equipment. Anna’s masters project was conducted under the supervision of Prof Ed Tate. She was investigating the optimization of cyclic peptides as inhibitors for Rab27A.

 

Anna has now joined Imperial College as a ICB CDT student and her research will focus on developing a chemical proteomic technology platform for investigating the interactome in cancel cells to identify intractable targets. This project is co-supervised by Prof. Ed Tate, Dr. Marco Di Antonio and Dr. Emanuela Cuomo.